Method for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 20, 1989
Grant Date -
N/A
app pub date -
Oct 21, 1987
filing date -
Oct 21, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method is provided for reducing the occurrence of anastomotic intimal hyperplasia in grafts of artery, vein, biologic or synthetic conduits having end-to-side distal anastomosis. The method includes administering a regimen of fractionated heparin to the subject. Administration of the fractionated heparin can be either intravenously, intraperitoneally, subcutaneously or orally. Preferred dosage is 50-80 mg./kg. body weight per day.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully